Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ulcer and gastritis.

W K Leung1, D Y Graham

  • 1Dept. of Medicine and Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, China.

Endoscopy
|February 24, 2001
PubMed
Summary
This summary is machine-generated.

Helicobacter pylori and NSAIDs remain key causes of peptic ulcers and gastritis. New COX-2 inhibitors may alter NSAID-related complications, but long-term clinical benefits require further study.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Microsatellite instability in gastric intestinal metaplasia in patients with and without gastric cancer.

The American journal of pathology·2000
Same author

Helicobacter pylori and gastric cancer: both primary and secondary preventive measures are required.

Archives of internal medicine·2000
Same author

Proinflammatory activation of neutrophils and monocytes by Helicobacter pylori is not associated with cagA, vacA or picB genotypes.

APMIS : acta pathologica, microbiologica, et immunologica Scandinavica·2000
Same author

Modified Genta triple stain for identifying Helicobacter pylori.

Journal of clinical pathology·2000
Same author

Furazolidone combination therapies for Helicobacter pylori infection in the United States.

Alimentary pharmacology & therapeutics·2000
Same author

H. pylori in the pathogenesis of duodenal ulcer: interaction between duodenal acid load, bile, and H. pylori.

The American journal of gastroenterology·2000
Same journal

Correction: A novel technique for endoscopic stepwise clamping and resection of giant pedunculated colonic polyps.

Endoscopy·2026
Same journal

Feasibility and safety of an adaptive endoscopic resection algorithm guided by the muscle-retracting sign for early rectal cancer.

Endoscopy·2026
Same journal

Is ERCP losing its dominance to endoscopic ultrasound-guided biliary drainage for malignant distal biliary obstruction?

Endoscopy·2026
Same journal

Endoscopic ultrasound-guided gallbladder drainage for distal malignant biliary obstruction: It's not the tool - but knowing which one to use!

Endoscopy·2026
Same journal

Endoscopic closure of a large gastric mucosal defect using a novel endoscopic suturing device in a porcine model.

Endoscopy·2026
Same journal

Anchor clip-assisted detachable loop ligation for definitive hemostasis and closure of a high-risk bleeding gastric ulcer.

Endoscopy·2026
See all related articles

Area of Science:

  • Gastroenterology
  • Internal Medicine

Background:

  • Peptic ulcers and gastritis are primarily caused by Helicobacter pylori and nonsteroidal anti-inflammatory drugs (NSAIDs).
  • While H. pylori prevalence decreases in developed nations, it remains a global cause of peptic ulcers.
  • The connection between H. pylori gastritis and gastroesophageal reflux is increasingly recognized, with H. pylori potentially reducing acid production and esophagitis.

Purpose of the Study:

  • To review recent literature on peptic ulcer disease and gastritis.
  • To discuss the ongoing impact of H. pylori and NSAIDs on gastrointestinal health.
  • To examine the evolving landscape of NSAID-related complications with the introduction of COX-2 inhibitors.

Main Methods:

  • Literature review of recent studies on peptic ulcer and gastritis.

Related Experiment Videos

  • Analysis of findings related to Helicobacter pylori and NSAID interactions.
  • Evaluation of the impact of new COX-2 specific inhibitors on gastroduodenal complications.

    • Main Results:

    • H. pylori continues to be a significant global factor in peptic ulcers, despite declining prevalence in some regions.
    • H. pylori-induced gastritis is linked to reduced gastric acid, potentially mitigating reflux and esophagitis.
    • New COX-2 inhibitors show promise in reducing endoscopic ulcers with short-term use, but clinical outcomes like bleeding and perforation need further investigation.

    Conclusions:

    • Helicobacter pylori and NSAIDs remain central to peptic ulcer and gastritis research.
    • The role of H. pylori in relation to gastroesophageal reflux warrants continued attention.
    • The long-term clinical efficacy and safety of COX-2 inhibitors for preventing severe NSAID-related gastroduodenal complications require further evaluation.